期刊文献+

炎症性肠病并发常见机会性病毒感染患者的临床特点及处理策略 被引量:10

Opportunistic Viral Infections in Patients with Inflammatory Bowel Disease:Clinical Features and Management Strategies
下载PDF
导出
摘要 炎症性肠病(IBD)是一种慢性炎症性肠道疾病,主要包括溃疡性结肠炎(UC)和克罗恩病(CD)。目前,虽然IBD的发病机制尚未完全明确,但已明确其是一种在胃肠道表现出异常免疫反应的自身免疫性疾病,因此包括激素、免疫抑制剂及生物制剂在内的药物治疗已成为IBD的主要治疗方式。免疫抑制剂等主要通过有针对性地干预免疫反应的不同阶段而达到治疗效果,但由于IBD患者营养状况、免疫功能较差及相关药物对免疫功能的抑制,其抵御病原体侵袭的能力被削弱,机会性感染风险明显升高。本文主要分析了IBD并发常见机会性病毒感染患者的临床特点及处理策略,以期为临床有效管理此类患者提供参考。 Inflammatory bowel disease(IBD)is a term used to describe ulcerative colitis and Crohn's disease,manifested by chronic inflammation of the gastrointestinal tract.Although its pathogenesis remains unclear,it has been recognized as an autoimmune disease with abnormal immune response in the gastrointestinal tract.Current treatments mainly include drug therapies such as steroid,immune inhibitors and biological agents,and their effects mainly attribute to targeted intervention in different stages of immune response in the process of IBD.As the body's defense against pathogens is impaired due to declined nutritional and immune status as well as application of immunomodulatory,patients with IBD have a significant increase in the risk of opportunistic infection.This paper mainly reviewed the clinical features and management strategies of opportunistic viral infections in patients with IBD,hoping to provide a reference for clinical efficient management.
作者 吴榕 王英德 毛靖伟 WU Rong;WANG Yingde;MAO Jingwei(Department of Gastroenterology,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China)
出处 《中国全科医学》 CAS 北大核心 2021年第15期1853-1860,共8页 Chinese General Practice
基金 国家自然科学基金资助项目(81770551)。
关键词 炎性肠疾病 结肠炎 溃疡性 CROHN病 机会致病菌感染 机会性病毒感染 病毒性疾病 综述 Inflammatory bowel diseases Colitis,ulcerative Crohn disease Opportunistic infections Opportunistic viral infection Virus diseases Review
  • 相关文献

参考文献2

二级参考文献66

  • 1Elisabetta Franco,Barbara Bagnato,Maria Giulia Marino,Cristina Meleleo,Laura Serino,Laura Zaratti.Hepatitis B:Epidemiology and prevention in developing countries[J].World Journal of Hepatology,2012,4(3):74-80. 被引量:41
  • 2C. Garcia-Vidal,S. Rodríguez-Fernández,S. Teijón,M. Esteve,M. Rodríguez-Carballeira,J. M. Lacasa,G. Salvador,J. Garau.Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention[J]. European Journal of Clinical Microbiology & Infectious Diseases . 2009 (4)
  • 3Keisuke Ojiro,Makoto Naganuma,Hirotoshi Ebinuma,Hiroyoshi Kunimoto,Shinichiro Tada,Haruhiko Ogata,Yasushi Iwao,Hidetsugu Saito,Toshifumi Hibi.Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab[J]. Journal of Gastroenterology . 2008 (5)
  • 4Lok AS,,Mcmahon BJ.Chronic Hepatitis B:Update 2009. Hepatology . 2009
  • 5Chevaux JB,Bigard MA,Bensenane M,Oussalah A,Jarlot S,Belle A,Nani A,Bronowicki JP,Peyrin-Biroulet L.Inflamma- tory bowel disease and hepatitis B and C. Gastroenterology Clinics of North America . 2009
  • 6Mindikoglu AL,Regev A,Schiff ER.Hepatitis B virus reactivation after cytotoxic chemotherapy:the disease and its prevention. Clinics in Gastroenterology . 2006
  • 7A Hanbali,Y Khaled.Incidence of hepatitis B reactivation following rituximab therapy. American Journal of Hematology . 2009
  • 8Bernuau,J,Rueff,B,Benhamou,JP.Fulminant and subfulminant liver failure. Seminars in Liver Disease . 1986
  • 9Kohrt HE,Ouyang DL,Keeffe EB.Antiviral prophylaxis forchemotherapy-induced reactivation of chronic hepatitis B virusinfection. Alimentary Pharmacology and Therapeutics . 2007
  • 10S Madonia,A Orlando,D Scimeca,M Olivo,F Rossi,M Cottone.Occult hepatitis B and infliximab-induced HBV reactivation. Inflammatory Bowel Diseases . 2007

共引文献15

同被引文献90

引证文献10

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部